Healthcare technology is entering its next phase of growth. Lanas is built for it.
Why we exist
Lanas exists to do something specific in healthcare – enabling better care delivery through innovation and technology.
Our technology makes care more efficient for the clinicians who deliver it, and more accessible for the patients who need it.
We deliver our mission by enhancing our existing products and platforms, and acquiring new technology that aligns with our vision. Where a traditional buy-and-build model acquires and maintains, Lanas acquires and ignites. The insight built on decades of EHR experience, accumulated across verticals and three continents, informs every product decision, every integration, and every iteration. What succeeds in one market is considered for its potential across others. ‘Bolt-through’ innovations – technology built or acquired to work across multiple verticals – multiply the value of a single capability across the entire business.
This model of cross-vertical value creation is what differentiates Lanas. It is also what makes our products and platforms more valuable over time than they would be independently.
How we got here
We formed Lanas in 2025, backed by leading global private equity firm TA Associates, bringing together a portfolio of established healthcare technology under a single company, a unified strategy, and revenues of c.€120 million.
The transition has been deliberate, and the result is a business that operates with clarity of structure, accountability of leadership, and a defined strategy for what comes next.
The business was restructured from geographic operating units into the four technology market vertical model, with functions centralised where efficiency demanded it. A single global leadership team took responsibility for strategy and consistent execution. And investment was directed into product innovation, including the development of a proprietary, closed loop AI capability for customers.
Why verticals
Each of our four product market verticals operates in a similar market, with similar challenges, serving similar customers. Over time, that builds into a depth of insight into how healthcare technology operates at both a global and an intricately local level. Patterns emerge and integration becomes faster. The instinct for what works, and what doesn’t, sharpens with every acquisition and every product decision.
Our first acquisition in late 2025, Billink Payments, was acquired as a single-market integrated payments and analytics. It has since been integrated across two of Lanas’s market verticals – exceeding 1 million+ payment transactions – without rebuilding the product or the commercial model. For a business with an active M&A programme, the ability to integrate and scale is a meaningful advantage.
Where we are focusing
We’re strategically focused on three key areas to maximise how we deliver value.
Continuous product innovation. We prioritise ongoing investment in product development, accreditation, and the integration of emerging technologies, including AI, ASR, and analytics, to maintain and strengthen our customer offering.
Strategic M&A. We focus on mergers and acquisitions that enhance product value, expand market vertical impact, or introduce innovative technologies that add value across the organisation.
Partnerships. Our partnerships span the healthcare ecosystem – from technology innovators and industry partners, to health systems and clinical organisations and colleges. These are long-cultivated relationships that prove further insight, credibility, and ongoing collaboration that brings value to our customers.
Where we are going
Continued investment in our products and platforms will drive value from within – deepening capability, strengthening market position, and ensuring our core technology continues to deliver value to customers.
Strategic acquisitions will add to that too, bringing new capability and new market presence into a company that knows how to absorb and leverage them.
And increasingly, our future includes AI. We’re actively integrating intelligent capabilities across our products, combining decades of healthcare data infrastructure with AI that is closed-loop, secure, and built with a clear understanding of clinical guardrails – delivering real, measurable value to the health systems that depend on us.
Ultimately, the measure of Lanas is not solely commercial performance. It is whether our products and platforms make healthcare work better for the people that depend on it.
We believe Lanas represents a unique healthcare technology business. not because of scale alone, but because of our foundations — the depth of market knowledge, the quality of the products, and an instinct for innovation that has been the catalyst for growth from the beginning.
